HIIFS
BNTX icon

Harel Insurance Investments & Financial Services’s BioNTech BNTX Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-800
Closed -$205K – 718
2021
Q4 		$205K Buy
+800
New +$219K ﹤0.01% 393
2020
Q3 		– Sell
-700
Closed -$47K – 630
2020
Q2 		$47K Buy
+700
New +$35K ﹤0.01% 405

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Harel Insurance Investments & Financial Services's BNTX Position: Q1 2022 in Review

Harel Insurance Investments & Financial Services sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 800 shares — an estimated $205K sold.

Harel Insurance Investments & Financial Services first reported a position in BNTX in Q2 2020 and held it in 2 quarters. The position peaked at $205K in Q4 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Harel Insurance Investments & Financial Services reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 800 BioNTech shares in Q1 2022, an estimated $205K.
  • Harel Insurance Investments & Financial Services first reported a position in BioNTech in Q2 2020 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's BioNTech position peaked at $205K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2022, filed 3 May 2022.